FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3103187414> ?p ?o ?g. }

• W3103187414 endingPage "930" @default.
• W3103187414 startingPage "920" @default.
• W3103187414 abstract "L’objectif de ce travail était de faire une synthèse des connaissances actuelles sur le traitement du syndrome clinique d’hyperactivité vésicale réfractaire. Une revue systématique de la littérature à partir de PubMed, Embase et Google Scholar a été menée en juillet 2020. Actuellement, le traitement du syndrome clinique d’hyperactivité vésicale réfractaire repose sur la stimulation du nerf tibial qu’elle se fasse par voie percutanée ou transcutanée, la neuromodulation sacrée et les injections intradétrusoriennes de toxine botulique. Ces traitements conservateurs ont mis au second plan les traitements chirurgicaux qui relèvent principalement de la cystectomie sus-trigonale avec entérocystoplastie d’agrandissement. Plusieurs traitements potentiels sont en cours d’évaluation mais ne peuvent aujourd’hui être proposés que dans le cadre de protocoles de recherche clinique. Les traitements « conservateurs » du syndrome clinique d’hyperactivité vésicale réfractaire ont fait la preuve de leur efficacité. D’autres traitements pourraient venir enrichir les options thérapeutiques. The aim was to synthesize current knowledge on refractory overactive bladder treatments. A systematic literature review based on PubMed, Embase and Google Scholar was conducted in July 2020. Today, refractory overactive bladder treatment includes tibial nerve stimulation, whether percutaneously or transcutaneously, sacral neuromodulation, and botulinum toxin A detrusor injections. These conservative treatments have marginalized surgical treatments, which mainly involve supratrigonal cystectomy with augmentation cystoplasty. Several potential new treatments are being evaluated but can only be currently offered as part of clinical research protocols. “Conservative” treatments for refractory overactive bladder have been shown to be effective. Other treatments could enrich the treatment options." @default.
• W3103187414 created "2020-11-23" @default.
• W3103187414 creator A5034411257 @default.
• W3103187414 creator A5056180851 @default.
• W3103187414 date "2020-11-01" @default.
• W3103187414 modified "2023-10-17" @default.
• W3103187414 title "Traitement du syndrome clinique d’hyperactivité vésicale non neurologique réfractaire" @default.
• W3103187414 cites W1418815612 @default.
• W3103187414 cites W1570728931 @default.
• W3103187414 cites W1574814880 @default.
• W3103187414 cites W1967927925 @default.
• W3103187414 cites W1970886028 @default.
• W3103187414 cites W1972383603 @default.
• W3103187414 cites W1984706417 @default.
• W3103187414 cites W1989913323 @default.
• W3103187414 cites W1995717681 @default.
• W3103187414 cites W2000061768 @default.
• W3103187414 cites W2000095279 @default.
• W3103187414 cites W2007097143 @default.
• W3103187414 cites W2012878999 @default.
• W3103187414 cites W2020769178 @default.
• W3103187414 cites W2021257414 @default.
• W3103187414 cites W2035491712 @default.
• W3103187414 cites W2043938107 @default.
• W3103187414 cites W2047813421 @default.
• W3103187414 cites W2058279126 @default.
• W3103187414 cites W2059528868 @default.
• W3103187414 cites W2061994989 @default.
• W3103187414 cites W2062168648 @default.
• W3103187414 cites W2062955989 @default.
• W3103187414 cites W2072032461 @default.
• W3103187414 cites W2072707043 @default.
• W3103187414 cites W2088106095 @default.
• W3103187414 cites W2089461537 @default.
• W3103187414 cites W2092900164 @default.
• W3103187414 cites W2095113407 @default.
• W3103187414 cites W2096816913 @default.
• W3103187414 cites W2113794636 @default.
• W3103187414 cites W2118985462 @default.
• W3103187414 cites W2119981003 @default.
• W3103187414 cites W2132279199 @default.
• W3103187414 cites W2154268224 @default.
• W3103187414 cites W2328680462 @default.
• W3103187414 cites W2342916227 @default.
• W3103187414 cites W2395426978 @default.
• W3103187414 cites W2528575688 @default.
• W3103187414 cites W2587041659 @default.
• W3103187414 cites W2590428970 @default.
• W3103187414 cites W2613925354 @default.
• W3103187414 cites W2736558198 @default.
• W3103187414 cites W2769050772 @default.
• W3103187414 cites W2769197915 @default.
• W3103187414 cites W2782182842 @default.
• W3103187414 cites W2783280708 @default.
• W3103187414 cites W2792161212 @default.
• W3103187414 cites W2796025441 @default.
• W3103187414 cites W2797201471 @default.
• W3103187414 cites W2797547592 @default.
• W3103187414 cites W2803463152 @default.
• W3103187414 cites W2896526042 @default.
• W3103187414 cites W2898314478 @default.
• W3103187414 cites W2966711231 @default.
• W3103187414 cites W2987462114 @default.
• W3103187414 cites W2999509698 @default.
• W3103187414 cites W3000079205 @default.
• W3103187414 cites W3007263193 @default.
• W3103187414 cites W3025579793 @default.
• W3103187414 cites W3042035786 @default.
• W3103187414 cites W4213351464 @default.
• W3103187414 cites W4231359556 @default.
• W3103187414 cites W4245187582 @default.
• W3103187414 doi "https://doi.org/10.1016/j.purol.2020.09.004" @default.
• W3103187414 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33220820" @default.
• W3103187414 hasPublicationYear "2020" @default.
• W3103187414 type Work @default.
• W3103187414 sameAs 3103187414 @default.
• W3103187414 citedByCount "1" @default.
• W3103187414 countsByYear W31031874142023 @default.
• W3103187414 crossrefType "journal-article" @default.
• W3103187414 hasAuthorship W3103187414A5034411257 @default.
• W3103187414 hasAuthorship W3103187414A5056180851 @default.
• W3103187414 hasBestOaLocation W31031874141 @default.
• W3103187414 hasConcept C126894567 @default.
• W3103187414 hasConcept C142724271 @default.
• W3103187414 hasConcept C204787440 @default.
• W3103187414 hasConcept C2778941218 @default.
• W3103187414 hasConcept C29456083 @default.
• W3103187414 hasConcept C3017551082 @default.
• W3103187414 hasConcept C71924100 @default.
• W3103187414 hasConceptScore W3103187414C126894567 @default.
• W3103187414 hasConceptScore W3103187414C142724271 @default.
• W3103187414 hasConceptScore W3103187414C204787440 @default.
• W3103187414 hasConceptScore W3103187414C2778941218 @default.
• W3103187414 hasConceptScore W3103187414C29456083 @default.
• W3103187414 hasConceptScore W3103187414C3017551082 @default.
• W3103187414 hasConceptScore W3103187414C71924100 @default.
• W3103187414 hasIssue "14" @default.
• W3103187414 hasLocation W31031874141 @default.

• next